March 2025 | 11 Such innovative endeavours are driven by the internal culture cultivated at OMG, one of stewardship, empowerment, and collaboration. The team is led by some of the industry’s most respected leaders, including John Leith, its Founder and a pioneer in the Australian medicinal cannabis and wellness space; Rohit Bhuta, possessing over three decades of experience in leadership across multiple industries and jurisdictions; Emeritus Professor Alan Bensoussan, Chief Science Officer and former Director of NICM; and Dr. Dev Banerjee, Chief Medical Officer and a renowned sleep specialist with a vision for evidence-based cannabinoid therapy. Renowned around the world for redefining integrative healthcare with its innovative and patient-centred solutions, OMG plans to continue achieving excellence through science-based research throughout 2025. From expanding its research and product pipeline, developing new products under its own IP, and advancing its clinical trial programmes, to forming new JVs with likeminded entities and expanding the reach of its clinic network, OMG is sure to pave the way in alternative medicine through unparalleled collaboration, determination, and unbridled innovation. “Innovation continues to be at the heart of everything we do, as we develop new products under our own IP and broaden our treatment and preventative health range,” Rohit announces. “2025 marks an exciting year of growth, innovation, and impact for OMG as we remain committed to transforming health outcomes on a global scale.” Contact: Rohit Bhuta Company: OZ MEDICANN GROUP Web Address: www.omgpharma.com.au Founded in 2017, OMG is a science-led, patient-first biotech company redefining integrative healthcare, on a mission to ensure that patients have access to the right medicine at the right time, wherever they are located. To achieve this mission, OMG proudly partners with world-renowned research institutions, including the National Institute of Complementary Medicine in Australia and the Medical Institute of Research New Zealand, to ensure that each product it delivers is clinically tested and scientifically validated. Committed to research and efficacy, OMG allows its core values of being ‘humble, hungry, and smart’ to drive its operations. The company listens first, always learning from science and patients; pursues innovation relentlessly, committed to improving lives; and leads with research, data, and integrity to deliver real and effective healthcare solutions. These values have shaped OMG’s collaborative, purpose-driven culture, and have allowed the company to build one of the most dynamic and forward-thinking biotech companies throughout Australia. “We are more than a company – we are an ecosystem of innovation, delivering clinically validated cannabinoid medicines, AI-powered health technologies, and holistic wellness solutions,” Rohit tells us. “OMG’s unique value lies in our integrated healthcare ecosystem, where cutting-edge science, AI technology, and clinical services converge to deliver better outcomes for patients and clinicians alike. Unlike others in the market, OMG doesn’t repackage or whitelabel – we develop our own proprietary products, backed by patentpending innovations and intellectual property that is uniquely ours.” Oz Medicann Group (OMG) is spearheading innovation in the cannabinoid medicine space by delivering a fully integrated, patientfirst ecosystem that ensures access to high-quality, evidencebased treatments—anytime, anywhere. Through its science-led pharmaceutical division, cutting-edge digital health platform Ask Sam, and national clinical network The New Clinic, OMG is revolutionising how patients connect with their healthcare. By combining AI-driven support, real-time prescription management, and a diverse range of proprietary medicines, OMG is removing traditional barriers and redefining what accessible, personalised care looks like in Australia and beyond. To further its mission of making alternative medicine accessible to all, OMG has also established a number of partnerships for joint ventures with likeminded companies and is looking forward to the launch of Australia’s first cannabis functional teas in partnership with MJF Holdings, the parent company of Dilmah Tea. This joint venture will see the formulation, manufacturing, and distribution of hemp-based and CBD functional teas and beverages. Together, OMG and MJF Holdings has a combined distribution footprint of 108, providing a platform to create true global impact. The global healthcare sector is dramatically shifting towards personalised and integrative medicine, as patients seek more natural, evidence-based alternatives. Australia’s progressive regulatory landscape has enabled the TGA to lead the way in revolutionary medication, such as over-the-counter CBD alternatives. OZ MEDICANN GROUP (OMG) is currently positioned at the forefront of this shift, championing Australia’s leadership in medicinal cannabis regulation to develop functional wellness products and clinically validated cannabinoid medicines. As the biotech innovator is named in the Australian Enterprise Awards 2025, Rohit Bhuta, Group Chief Executive Officer tells us more. Hemp Health & Wellness Company of the Year 2025 & Product Innovation Excellence Award 2025
RkJQdWJsaXNoZXIy NTY1MjM3